{"id":"5345517c-4a06-4d7e-93ba-a99a9b9ecb86","kind":"institutions","code":"UB-I2655","name":"Jiayin Fund","nameBasis":"transliterated","summary":"Jiayin Fund, a venture capital firm focused on technology investments.","description":"Jiayin Fund, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"佳银基金","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:30:25.321Z","englishUpdatedAt":"2026-10-15T17:35:39.013Z","reviewedAt":"2026-10-15T17:35:39.013Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6ef2a00f6c103cc5447ae0ef4be5e7c1c1d86efbcb251f0bb213fbb7a53092cd","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"佳银基金，一家专注科技领域投资的风险投资机构。","sources":[],"related":[{"id":"a5d162ba-fab7-47ee-ab19-afb2e114ba51","kind":"news","code":"a5d162ba-fab7-47ee-ab19-afb2e114ba51","name":"Zhiran Medical Raises RMB 600M in Equity Investment","nameBasis":"translated-title","summary":"On September 22, 2026, Beijing-based Zhiran Medical, a next-generation flexible brain-computer interface platform developer, raised RMB 600 million from over ten investors including Shunxi Fund, Sequoia China, Junlian Capital, Shunwei Capital, Meituan Longzhu and CAS Star. It was founded by Dr. Song Qi.","description":"","country":null,"category":null,"originalName":"智冉医疗完成6亿元股权投资","eventDate":"2026-09-22T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-14T11:44:26.930Z","englishUpdatedAt":"2026-10-15T16:49:02.926Z","reviewedAt":"2026-10-15T16:49:02.926Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"20f67d25ca26c8e11d0aa3e41f47b9d223978732510f400ead359c6f99f688e3","companyId":"1ef56388-71d4-4402-bbd4-73a3657f5fb4","foundedYear":null,"logoUrl":null,"path":"/news/a5d162ba-fab7-47ee-ab19-afb2e114ba51"},{"id":"55168274-31ef-440b-a1f2-e58fc5f91ed0","kind":"news","code":"55168274-31ef-440b-a1f2-e58fc5f91ed0","name":"Zhiran Medical raises RMB 300 million in Series A+ financing","nameBasis":"translated-title","summary":"On 2026-02-11, according to Xiniu Data, Zhiran Medical completed Series A+ financing, raising RMB 300 million. Investors were Yuansheng Venture Capital, Junlian Capital, Hongshan China, Xingze Capital and others.","description":"","country":null,"category":null,"originalName":"智冉医疗完成A+轮融资，金额3亿人民币","eventDate":"2026-02-11T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-16T19:46:29.324Z","englishUpdatedAt":"2026-10-18T08:52:13.862Z","reviewedAt":"2026-10-18T08:52:13.862Z","snapshotAt":"2026-10-18T08:51:49.337Z","sourceHash":"c97757e0251430fd7f15e8bd58e5ff9cac832a3069db603d9d6bc989d9bf75e2","companyId":"1ef56388-71d4-4402-bbd4-73a3657f5fb4","foundedYear":null,"logoUrl":null,"path":"/news/55168274-31ef-440b-a1f2-e58fc5f91ed0"}],"path":"/institutions/jiayin-fund","displayName":"佳银基金","displayNameLang":"zh","structured":{"city":null,"country":"China (mainland)","location":null,"role":null,"category":null,"company":null},"definition":"佳银基金 is a venture capital investor based in China (mainland) with 2 recorded investments.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/institutions/jiayin-fund"}